Spondyloarthritis The Changing Landscape Today An Issue of Rheumatic Disease Clinics of North America 1st Edition at Meripustak

Spondyloarthritis The Changing Landscape Today An Issue of Rheumatic Disease Clinics of North America 1st Edition

Books from same Author: Baraliakos, Xenofon

Books from same Publisher: Elsevier

Related Category: Author List / Publisher List


  • Retail Price: ₹ 10543/- [ 5.00% off ]

    Seller Price: ₹ 10015

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Baraliakos, Xenofon
    PublisherElsevier
    Edition1st Edition
    ISBN9780323733779
    Pages240
    LanguageEnglish
    Publish YearMay 2020

    Description

    Elsevier Spondyloarthritis The Changing Landscape Today An Issue of Rheumatic Disease Clinics of North America 1st Edition by Baraliakos, Xenofon

    This issue of Rheumatic Disease Clinics, guest edited by Drs. Xenofon Baraliakos and Michael H. Weisman, Spondyloarthritis: The Changing Landscape Today, takes a very comprehensive look at all of the essential topics surrounding spondyloarthritis. This issue is one of four selected each year by Dr. Weisman, who is also our series consulting editor. This very comprehensive issue will include the following topics (among others): Molecular biology approaches to understanding SpA; Microbiome and its role in SpA; Classification criteria in axSpA; Administrative data and coding for axSpA; Approach to the patient with IBD and AxSpA; Axial PsA vs. Axial SpA with Psoriasis; Emerging imaging techniques in SpA; The future of imaging in axSpA; Treatment Recommendations vs. Treat to Target in axSpA; The future of axSpA treatmentAxSpA in the era of Precision Medicine; Quality of Life as an outcome in studies of axSpA; Gender differences in SpA; The patient's perspective on the burden of disease in axSpA; and Juvenile SpA.